Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-003623
Filing Date
2025-02-11
Accepted
2025-02-11 18:04:22
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 form4-02112025_110217.html 4  
1 form4-02112025_110217.xml 4 5456
  Complete submission text file 0001415889-25-003623.txt   6879
Mailing Address
Business Address
MATLIN DAVID J (Reporting) CIK: 0001251956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39813 | Film No.: 25611217

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)